STAT3 and neoplasm: Preferential activation of the STAT3 pathway by the permissive cytokine milieu has profound effects on the innate immune system components of the TME, which are largely mediated by tumor-associated macrophages/microglia (TAMs), myeloid-derived suppressor cells (MDSCs), and other cells [102].